|
AGPHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88720150617883E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.37090363902826E-11 |
| Normal-vs-Stage2 |
8.59723403578982E-12 |
| Normal-vs-Stage3 |
1.84696702376641E-12 |
| Normal-vs-Stage4 |
5.6129545455974E-12 |
| Stage1-vs-Stage2 |
1.973560E-01 |
| Stage1-vs-Stage3 |
3.775400E-03 |
| Stage1-vs-Stage4 |
4.600100E-02 |
| Stage2-vs-Stage3 |
2.593200E-01 |
| Stage2-vs-Stage4 |
7.537800E-01 |
| Stage3-vs-Stage4 |
4.828200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46660461552983E-11 |
| Normal-vs-AfricanAmerican |
2.38550290632134E-11 |
| Normal-vs-Asian |
4.38799999999961E-05 |
| Caucasian-vs-AfricanAmerican |
3.748000E-01 |
| Caucasian-vs-Asian |
5.221600E-01 |
| AfricanAmerican-vs-Asian |
3.765000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.36697378048257E-12 |
| Normal-vs-Female |
3.3451019731956E-11 |
| Male-vs-Female |
6.132000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.98947541668804E-12 |
| Normal-vs-Extreme_Weight |
6.30062668705023E-12 |
| Normal-vs-Obese |
7.61579688202119E-12 |
| Normal-vs-Extreme_Obese |
3.413400E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.768800E-01 |
| Normal_Weight-vs-Obese |
7.946200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.246200E-02 |
| Extreme_Weight-vs-Obese |
7.701000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.012100E-02 |
| Obese-vs-Extreme_Obese |
1.518040E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.65640892300235E-12 |
| Normal-vs-Age(41-60Yrs) |
1.25379706616968E-11 |
| Normal-vs-Age(61-80Yrs) |
2.00760519319942E-11 |
| Normal-vs-Age(81-100Yrs) |
1.07720000031009E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.401630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.109800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.003600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.259200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.861200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.199800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.12470041560664E-11 |
| Normal-VS-Type2 PRCC |
4.6243009421687E-12 |
| Normal-VS-KIRP CIMP |
2.31925589844195E-13 |
| Normal-VS-Unclassified PRCC |
7.90378873460895E-12 |
| Type1 PRCC-VS-Type2 PRCC |
5.421800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.896400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.611800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.997400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.432600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.184500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67068614287791E-12 |
| Normal-vs-N1 |
1.01585406753202E-13 |
| Normal-vs-N2 |
4.968100E-04 |
| N0-vs-N1 |
1.331570E-02 |
| N0-vs-N2 |
5.542800E-01 |
| N1-vs-N2 |
5.981200E-01 |
|
|
